Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.66%
#2 aelf aelf +22.78%
#3 Venom Venom +19.12%
#4 Bitway Bitway +13.51%
#5 Decred Decred +10.29%
#6 Pons Pons +9.78%
#7 TRIA TRIA +9.00%
#8 MarsCoin MarsCoin +8.85%
#9 Wibx Wibx +8.11%
#10 AtomOne AtomOne +7.71%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Nanologica AB (publ) Nanologica AB (publ)

Nanologica AB (publ)

NICA
Kedudukan dalam Saham #30456
Nanologica AB (publ), a nanotechnology company, develops, manufactures, and... Nanologica AB (publ), a nanotechnology company, develops, manufactures, and sells nanoporous silica particles for life science industry in China, India, the United State of America, and internationally. It offers NLAB Saga, a new generation silica for preparative chromatography; and SVEA, a pre-packaged columns for analytical chromatography; and high-performance liquid chromatography, a separation method based on different substances in a solution passing through a column at different paces. The company provides products for the analysis and purification of substances, with a focus on peptides drugs for the treatment of diabetes and obesity. Nanologica AB (publ) was incorporated in 2004 and is headquartered in Södertälje, Sweden.
Harga Saham
$0.05093225
Disegerakkan terakhir: 2026-08-18
Modal Pasaran
$16.74M
Perubahan (1 hari)
1.11%
Perubahan (1 tahun)
-68.04%
Negara
SE
Perdagangan Nanologica AB (publ) (NICA)

Kategori

Healthcare
Pendapatan untuk Nanologica AB (publ) (NICA)
Pendapatan pada 2026 TTM: 0
Menurut laporan kewangan terkini Nanologica AB (publ), pendapatan semasa syarikat ialah 0. Pada tahun 2026, syarikat memperoleh pendapatan sebanyak 0, sama dengan pendapatan pada tahun 2026 yang berjumlah 0. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Nanologica AB (publ) dari 2026 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Ubah
Tidak cukup data untuk tarikh yang disediakan.
Pendapatan untuk syarikat atau pesaing serupa
Syarikat Pendapatan Perbezaan Pendapatan Negara
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
$1.35B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
$26.37M -
US
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
- -
IT